Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients
- PMID: 18831698
- DOI: 10.1086/592352
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients
Comment on
-
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294. Clin Infect Dis. 2008. PMID: 18532884
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
